Open AccessImmunoproteasome Inhibition to Target AML with Activated RAS Pathways
Author(s) -
Connor M. Navis,
Klara E. Noble-Orcutt,
Rebecca S. LaRue,
Conner J. Hansen,
Ngoc A. Ha,
Alexandria L. Hillesheim,
Ryan Schulz,
DoHyung Kim,
David A. Largaespada,
Zohar Sachs
Publication year - 2016
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.v128.22.577.577
Subject(s) - neuroblastoma ras viral oncogene homolog , cancer research , mtorc1 , myeloid leukemia , pi3k/akt/mtor pathway , leukemia , bortezomib , myeloid , biology , immunology , medicine , cancer , multiple myeloma , microbiology and biotechnology , signal transduction , kras , colorectal cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom